Filing Details

Accession Number:
0001179110-20-001422
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-10 19:24:45
Reporting Period:
2020-02-06
Accepted Time:
2020-02-10 19:24:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1775522 Brent Neidig 3838 West Parkway Blvd.
West Valley City UT 84120
Chief Officer & Md Of China No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-06 283 $0.00 1,957 No 4 M Direct
Common Stock Disposition 2020-02-06 126 $80.71 1,831 No 4 F Direct
Common Stock Acquisiton 2020-02-06 783 $70.75 2,614 No 4 M Direct
Common Stock Disposition 2020-02-06 783 $79.00 1,831 No 4 S Direct
Common Stock Acquisiton 2020-02-06 1,420 $65.26 3,251 No 4 M Direct
Common Stock Disposition 2020-02-06 1,420 $80.50 1,831 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2020-02-06 283 $0.00 283 $0.00
Common Stock Stock - Settles Stock Appreciation Right Disposition 2020-02-06 7,500 $0.00 7,500 $70.75
Common Stock Stock - Settles Stock Appreciation Right Disposition 2020-02-06 7,500 $0.00 7,500 $65.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,631 No 4 M Direct
0 2019-09-01 2020-03-01 No 4 M Direct
0 2019-11-03 2020-06-03 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  2. On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.
  3. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.